New Research Suggests GLP-1 Drugs May Help Lower Cancer Risk

New research is providing more evidence that GLP-1 drugs—a class of medications originally created to treat diabetes—might offer unexpected health benefits. These drugs, which work by changing how the brain and gut manage hunger and digestion, are already well-known for helping people lose weight and manage heart disease. Now, scientists are exploring whether these medications can also help prevent or control cancer.

According to NPR Health, this topic was a major focus at the recent meeting of the American Society of Clinical Oncology (ASCO). The organization highlighted four different studies that suggest a link between GLP-1 use and a lower risk of developing certain cancers. One of the most significant studies looked at the medical records of over 10,000 patients who had early-stage cancer. The results showed that patients taking GLP-1 drugs had a lower risk of developing several types of cancer, including breast, liver, and lung cancer.

For some patients, the difference was quite clear. For example, in cases of non-small cell lung cancer, the rate of the disease progressing to a more serious, late stage was 22.3% for those not taking the medication. However, that number dropped to 10% for patients who were using GLP-1 drugs. These findings are particularly interesting because the protective effects were seen across many different types of cancer, not just those typically linked to obesity.

Another study presented at the conference focused specifically on breast cancer. By looking at mammogram images and prescription records, researchers found that women between the ages of 45 and 80 who took GLP-1 drugs were 30% less likely to develop breast cancer. Elizabeth McDonald, a radiologist at the University of Pennsylvania who helped lead this study, noted that the protective effect seemed stronger than what is usually seen with other weight-loss methods. She explained that while losing weight generally lowers cancer risk, the results from these drugs were so significant that weight loss alone could not explain them.

So, how might these drugs work? Experts believe there is more happening than just weight loss. McDonald and other researchers suspect that GLP-1 medications may trigger other important biological processes. One theory is that they reduce inflammation—the body’s response to injury or irritation—which is known to be a factor that can help cancer cells grow. By calming this process, the drugs might help the body fight off tumors more effectively.

Despite these exciting results, medical experts are urging caution. Dr. Julie Gralow, the chief medical officer of ASCO, pointed out that these studies are based on "retrospective" data. This means the researchers looked back at existing medical records rather than conducting a new, controlled experiment. Because of this, the studies do not account for other important factors, such as a patient’s diet, exercise habits, or other health conditions. "The latest data is still far from being able to conclude that GLP-1s are effective treatments for cancer," Gralow noted.

Even with these limitations, the findings align with what doctors already know about the relationship between lifestyle and health. It is well-established that obesity is a driver for about a dozen different types of cancer. Therefore, any treatment that helps manage weight and improves metabolic health is likely to have a positive impact on a patient’s overall cancer risk. Gralow added that this research fits into a larger body of knowledge about how healthy living is important both for preventing illness and for recovering after a cancer diagnosis.

As the medical community looks ahead, more rigorous research is already underway. Scientists are now planning new, direct clinical trials to better understand how these drugs interact with the body’s systems. These future studies will be essential to determine if GLP-1 drugs can truly be used as a tool to fight cancer, or if the current findings are simply a result of other factors. For now, the medical world is watching closely, hopeful that these common medications might provide a new way to improve long-term health outcomes for millions of people.